Skip to main content
. 2020 Aug 14;2020:4258035. doi: 10.1155/2020/4258035

Table 2.

Meta-analysis of the correlation between claudin-1 expression and clinicopathological factors of colorectal cancer.

Clinicopathological parameter No. of studies Participants RR (95% CI) Analysis model Heterogeneity Test for overall effect
I 2 (%) P value Z test P value
Tumor type (poorly vs. well) 6 1312 0.60 (0.49, 0.73) Fixed 33 0.19 4.94 <0.00001
Venous invasion (+ vs. -) 4 1029 0.81 (0.70, 0.95) Fixed 0 0.40 1.59 0.0010
Lymphatic invasion (+ vs. -) 4 1028 0.83 (0.74, 0.92) Fixed 0 0.42 3.32 0.0009
Perineural invasion (+ vs. -) 2 566 0.57 (0.25, 1.31) Random 80 0.03 1.33 0.18
Depth of invasion (T3, 4 vs. T1, 2) 4 1029 0.94 (0.72, 1.22) Random 70 0.02 0.47 0.64
Lymph node metastasis (+ vs. -) 4 1029 0.91 (0.82, 1.02) Fixed 0 0.60 1.66 0.10
Distant metastasis (+ vs. -) 2 379 0.88 (0.67, 1.15) Fixed 0 0.50 0.94 0.35
TNM stage (III, IV vs. I, II) 3 722 0.75 (0.54, 1.04) Random 69 0.04 1.71 0.09
Size (larger vs. smaller) 2 275 0.88 (0.60, 1.29) Fixed 0 0.68 0.65 0.52
Gender (male vs. female) 5 1185 1.02 (0.92, 1.14) Fixed 0 0.44 0.43 0.66
Age (older vs. younger) 2 275 1.15 (0.83, 1.60) Fixed 0 0.50 0.97 0.33
Tumor site (colon vs. rectum) 2 500 1.01 (0.87, 1.17) Fixed 0 0.81 0.10 0.92

RR: risk ratio; Random, random effects model; Fixed: fixed effect model.